Skip to main content
logo
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS · Delayed Price · Currency is USD
5.20
+2.19 (72.76%)
At close: Nov 7, 2025

RAJAF Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.251.251.250.880.05-
Revenue Growth
2236.31%-0.65%42.03%1555.66%--
Gross Profit
0.760.760.910.770.04-
Operating Income
-0.14-0.14-0.180.23-0.42-0.12
Net Income
-0.15-0.15-0.230.75-0.72-0.49
Earnings Per Share
-0.00-0.00-0.000.01-0.01-0.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
000.040.020.010.1
Total Debt
0.480.480.550.630.592.24
Net Cash (Debt)
-0.48-0.48-0.51-0.6-0.59-2.14
Net Cash Growth
------
Net Cash Per Share
-0.00-0.00-0.00-0.01-0.01-0.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.04-0.040.310.36-0.32-0.37
Capital Expenditures
---0.35-0.32--0.1
Free Cash Flow
-0.04-0.04-0.040.04-0.32-0.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
61.09%61.09%72.32%86.84%74.21%-
Operating Margin
-11.33%-11.33%-14.67%25.82%-778.78%-
Pretax Margin
-12.43%-12.43%-15.26%21.62%-778.76%-
Profit Margin
-12.43%-12.43%-18.05%85.17%-1350.92%-
FCF Margin
-2.88%-2.88%-2.97%4.56%-602.91%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
463.99463.99731.35---